Responses
Regular and young investigator award abstracts
Clinical trials in progress
434 Updated clinical data from the melanoma expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab
Compose a Response to This Article
Other responses
No responses have been published for this article.
